tiprankstipranks
Xilio Therapeutics, Gilead announce exclusive license agreement for XTX301
PremiumThe FlyXilio Therapeutics, Gilead announce exclusive license agreement for XTX301
16d ago
Xilio to get $43.5M upfront in pact with Gilead to develop/commercialize XTX301
PremiumThe Fly
Xilio to get $43.5M upfront in pact with Gilead to develop/commercialize XTX301
16d ago
Unusually active option classes on open March 22nd
PremiumThe Fly
Unusually active option classes on open March 22nd
22d ago
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
PremiumThe FlyJPMorgan biotech/pharma analysts hold an analyst/industry conference call
29d ago
Kevin Lofton Retires from Gilead Sciences Board
PremiumCompany Announcements
Kevin Lofton Retires from Gilead Sciences Board
29d ago
Gilead announces expiration of HSR waiting period for CymbaBay tender offer
PremiumThe Fly
Gilead announces expiration of HSR waiting period for CymbaBay tender offer
1M ago
Gilead receives option to license novel trispecific therapeutics  in Merus deal
PremiumThe FlyGilead receives option to license novel trispecific therapeutics in Merus deal
1M ago
Merus to receive $56M upfront in deal with Gilead to discover antigens
PremiumThe Fly
Merus to receive $56M upfront in deal with Gilead to discover antigens
1M ago
Gilead says new data further support use of Veklury in Covid-19 hospitalizations
PremiumThe Fly
Gilead says new data further support use of Veklury in Covid-19 hospitalizations
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100